Article
Acute myeloid leukaemia genomics.
British journal of haematology - 1 Nov 2017
Medinger Michael, Passweg Jakob R
Abstract excerpt
Acute myeloid leukaemia (AML) is a biologically complex, molecularly and clinically heterogeneous disease. Despite major advances in understanding the genetic landscape of AML and its impact on the pathophysiology and biology of the disease, standard treatment options have not significantly changed during the past three decades. AML is characterized by multiple somatically acquired mutations that affect genes of...
Topics
- Carcinogenesis
- Epigenesis, Genetic
- Genes, ras
- Genomics
- Humans
- Leukemia, Myeloid, Acute
- Molecular Targeted Therapy
- Mutation
- Mutation Accumulation
- Nuclear Proteins
- Nucleophosmin
- Prognosis
